February 28, 2025

New Member: Welcome in our cluster to CAVIGEN UG

New Member: Welcome in our cluster to CAVIGEN UG

CAVIGEN develops thermoformed microstructures for cell culture, including microcavities, porous microcavities, sensor-integrated microcavities (sensor arrays), and microchannels. Its patented technology enables precise oxygen measurement in 3D cell cultures, enhancing the physiological relevance of in vitro models, improving drug development processes, and reducing the need for animal testing.

CAVIGEN’s business model follows a razor-and-blade approach, offering a measurement device alongside disposable sensor arrays for organoid generation and analysis. In addition, the company provides custom development services to integrate its microstructures into existing systems.

Target customers include pharmaceutical companies, CROs, biotech firms, and organ-on-chip manufacturers developing advanced in vitro models. Currently preparing for market entry, CAVIGEN is testing its first prototypes with academic research groups and industry partners while actively seeking strategic partners and investors to accelerate adoption within the pharmaceutical sector.

If you would like to learn more, please visit their Website.
Looking forward to your active participation!

Our latest News

discover more
Overlooked Molecules in Metabolism

Overlooked Molecules in Metabolism

KIT researchers offer a new perspective on N-acetylated amino acids as potential buffers in cellular energy and metabolic balance When muscles work intensively or brown adipose tissue produces heat in response to cold, metabolism shifts into high gear. Under these conditions, levels of so-called N-acetylated amino acids increase. These are chemically modified amino acids to […]

A local barrier against respiratory viruses

A local barrier against respiratory viruses

Fraunhofer IGB News Brief / August 18, 2026 How can a respiratory virus be stopped before it spreads throughout the body? In the MucoShield project, Prime Vector Technologies, the NMI Tübingen, and Fraunhofer IGB are developing an intranasal vaccine candidate against human metapneumovirus (HMPV), which causes hundreds of thousands of cases of severe respiratory disease […]

Universität Heidelberg Achieves Top Placements in Shanghai Ranking

Universität Heidelberg Achieves Top Placements in Shanghai Ranking

Ruperto Carola in 59th place worldwide – among the “Top 3” in Germany Heidelberg University has achieved top placements in the 2026 Academic Ranking of World Universities. As in the previous year, it is one of the “Top 3” universities in Germany. In the global comparison, Ruperto Carola is in 59th position in this so-called […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp